Local Production of Hitachi Automatic Analyzer 3500 to Commence in China
Strengthening the delivery of solutions through an integrated manufacturing, marketing, and servicing system in China, where market demand is growing
TOKYO, Apr 15, 2021 - (JCN Newswire) - Hitachi High-Tech Corporation today announced that it will commence local production in China for assembled products of the Hitachi Automatic Analyzer 3500 for the Chinese market. Hitachi High-tech has been producing the small 3110 model clinical analyzers locally since 2018, but by adding the new 3500 model to our lineup, we will be able to meet growing demand in the larger market for medium-sized automatic clinical analyzer.
|Ceremony to commemorate the first locally produced device held at an exhibition in Chongqing, China,
at the end of March 2021|
In recent years, as the Chinese economy has developed, there have been rising concerns over population aging, public health management, and reforms to medical systems such as health insurance. Amid these issues, the market for medical devices and equipment in China is expected to continue growing.
The Hitachi High-Tech Group has been working to strengthen its manufacturing, marketing, and servicing system in China for its Bio & Medical Systems Business, aiming to expand into the Chinese in-vitro diagnostic (IVD) market, which continues to grow steadily. In 2013, Hitachi High-Tech increased the production capacity of Hitachi Instrument (Suzhou), Ltd. (General Manager: Nobuyuki Iwaki / HIS), by completing the construction of a new building that produces units and consumables for medical analyzers and other items. In 2016, Hitachi High-Tech Diagnostics (Shanghai) Co., Ltd. (General Manager: Zhang Tao) was established as a joint venture to undertake marketing and servicing operations for IVD analyzers and reagents in China. Working closely with Chinese reagent companies, this joint venture has expanded the delivery of total, one-stop solutions throughout China. In 2018, we commenced local production of the small 3110 model to increase our competitiveness and provide Chinese customers with products that meet the needs of the market.
In the Hitachi High-Tech Group's Bio & Medical Systems Business, production of assembled products for the 3500 model, a medium-sized clinical analyzer for the Chinese market, will commence at HIS, with the aim of further enhancing competitiveness in the Chinese market, where demand is growing. The 3500 is an automated analyzer capable of running three types of testing simultaneously: clinical chemistry, immunoassay, and blood coagulation. Local production will enable Hitachi High-Tech to manufacture high-quality and cost-competitive products that speedily address the needs of the Chinese market, reagent companies and customers.
The Hitachi High-Tech Group will strive to expand development and production in China and further enhance its ability to deliver IVD solutions to the Chinese market, thereby contributing to healthy, safe, and secure lives while working to create social and environmental value. Going forward, we will quickly grasp our customers' cutting-edge needs and continue to create high-added-value Focused Solutions in the fields of Bio/Medical and Safety/Security by utilizing "analysis technology".
Source: Hitachi, Ltd.
Sectors: Electronics, Cloud & Enterprise
Copyright ©2021 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
More Latest Release >>
Eisai and Merck & Co., Inc., Kenilworth, N.J., U.S.A. Receive Priority Review From FDA for LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Applications
May 07, 2021 11:08 JST
Showa Denko and Infineon Technologies Conclude Supply Contract and Development Agreement
May 06, 2021 17:30 JST
NEC Develops Neuroscience-inspired AI Technology for Time Series Analysis
May 06, 2021 14:13 JST
NEC Contributes to Development of Artificial DNA Aptamer that Binds to the Novel Coronavirus (SARS-CoV-2)
May 06, 2021 11:27 JST
Synopsis 2021: Hot Trends - Join the Summit 1-5 June
May 04, 2021 09:00 JST
Hard-Fought Hypercar Win for Toyota Gazoo Racing
May 03, 2021 04:25 JST
Komatsu, NTT DOCOMO, Sony Semiconductor Solutions and Nomura Research Institute to Launch "EARTHBRAIN"
Apr 30, 2021 16:35 JST
Toyota Developing Hydrogen Engine Technologies Through Motorsports
Apr 30, 2021 14:20 JST
Toyota Global Sales and Production Secures 90 Percent Level Year-on-Year in FY2021
Apr 28, 2021 16:46 JST
RESONA and Eisai Enter Into Business Alliance Aiming to Support People Living with Dementia and to Prevent Dementia in Saitama Prefecture, Japan
Apr 28, 2021 12:33 JST
NEC recognized in Gartner Magic Quadrant for 5G Network Infrastructure for Communications Service Providers as a Visionary
Apr 28, 2021 11:05 JST
LEXUS DESIGN AWARD 2021 Grand Prix Winner Announced
Apr 27, 2021 17:38 JST
AEON GLOBAL SCM and Toyota Starts to Consider Collaboration on Logistics Improvement and Carbon Neutrality Initiatives
Apr 27, 2021 16:15 JST
Suzuki, Subaru, Daihatsu, Toyota and Mazda Reach Agreement on Joint Development of Technical Specifications for Next-generation Vehicle Communications Devices
Apr 27, 2021 14:35 JST
MHIEC Supplies Incinerators for First Waste-to-Energy Plant in Xiaogan, Hubei Province, China
Apr 27, 2021 11:22 JST
Woven Planet Holdings, a Subsidiary of Toyota, Announces Acquisition of Lyft's Level 5 Division to Accelerate Software Innovation for Automated Driving Mobility
Apr 27, 2021 09:00 JST
Mitsubishi Heavy Industries Partner in Newly Established Hamburg Hydrogen Network to 'Make Hamburg Greener'
Apr 26, 2021 17:27 JST
NTT and Fujitsu Embark on Strategic Alliance to Drive "Realization of Sustainable Digital Society"
Apr 26, 2021 14:05 JST
AD ECU and OTA Unit Adopted in New Model Legend Capable of Over-the-Air (OTA) Vehicle Control Software Updating
Apr 26, 2021 11:35 JST
Honda to be Title Sponsor of the 2021 FIA Formula One Japanese Grand Prix
Apr 26, 2021 10:16 JST